--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Tesla
TSLA
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.340
- -0.010-0.74%
Close Dec 17 16:00 ET
40.04MMarket Cap-0.67P/E (TTM)
1.370High1.320Low151.96KVolume1.340Open1.350Pre Close203.30KTurnover1.05%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.46P/B19.39MFloat Cap0.87052wk Low--Dividend TTM14.47MShs Float23.580Historical High--Div YieldTTM3.70%Amplitude0.870Historical Low1.337Avg Price1Lot Size
AN2 Therapeutics Key Stats
AN2 Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
AN2 Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data